Table 1 Meta-analysis of the prevalence of types of tuberculosis drug resistance
From: Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis
Type | N | Sample size | I2 | Begg and Mazumdar correlation test | Meta-analysis of Prevalence (95% CI) |
|---|---|---|---|---|---|
Multi drug-resistant TB | 148 | 318,430 | 99.6 | P = 0.008 | 11.6% (9.1–14.5%) |
Isoniazid resistant TB | 98 | 102,260 | 99.03 | P = 0.02 | 15.7% (13.7–17.9%) |
Rifampin resistant TB | 109 | 215,660 | 98.9 | P = 0.00045 | 9.4% (7.8–11.2%) |
Single drug resistant TB | 35 | 45,147 | 98.5 | P = 0.139 | 11.8% (9.2–15.2%) |
Extensive drug resistant TB | 56 | 350,420 | 98.8 | P = 0.938 | 2.5% (2–3%) |